JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, T. R.
Right arrow Articles by Drazen, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, T. R.
Right arrow Articles by Drazen, J. M.

Serotonin-induced pulmonary responses are mediated by the 5-HT2 receptor in the mouse

TR Martin, ML Cohen and JM Drazen

Pulmonary Division, Ina Sue Perlmutter Laboratory, Children's Hospital, Boston, Massachusetts.

C57BL/6 mice exhibit acute transient decreases in lung conductance (GL) and dynamic compliance (Cdyn) after intravenous administration of serotonin (5-HT). To identify the specific agonist receptor subtypes responsible for this bronchoconstriction, we measured changes in pulmonary function in C57BL/6 mice in response to intravenous infusion of 5-HT receptor subtype-selective agonists and to 5-HT in the presence of antagonists selective for the 5-HT2 or 5-HT3 receptor subtypes. Agonists selective for the 5-HT1A/1B/1D or 5-HT3 receptor subtypes induced minimal or undetectable pulmonary responses, whereas infusion of alpha-methyl-5-hydroxytryptamine, a 5-HT2 receptor-selective agonist, led to dose-related decreases in Cdyn and GL. The selective 5- HT3 receptor antagonist, LY278584 maleate, (1.0 mg/kg i.v.) caused no detectable reduction in the response to 100 micrograms/kg of 5-HT. In contrast, treatment with the 5-HT2 receptor antagonist LY53857 (10 micrograms/kg i.v.) resulted in a significant diminution of the pulmonary response observed after infusion of 100 micrograms/kg of 5- HT. Dose-response relationships were established for 5-HT in experiments in which each mouse was treated with a single dose of 5-HT without antagonist or after LY53857. Compared with responses to doses of 5-HT of more than 100 micrograms/kg in the absence of antagonist, pulmonary responses to 5-HT after infusion of 10 micrograms/kg of LY53857 were significantly reduced; 100 micrograms/kg of LY53857 nearly abolished the responses to all doses of 5-HT.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 268, Issue 1, pp. 104-109, 01/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
G. A. Volgyesi, L. N. Tremblay, P. Webster, N. Zamel, and A. S. Slutsky
A new ventilator for monitoring lung mechanics in small animals
J Appl Physiol, August 1, 2000; 89(2): 413 - 421.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. Wang, M. Post, and E. Cutz
Expression of Serotonin Receptor 2c in Rat Type II Pneumocytes
Am. J. Respir. Cell Mol. Biol., June 1, 1999; 20(6): 1175 - 1180.
[Abstract] [Full Text]


Home page
ThoraxHome page
P. Egermayer, G I. Town, and A. J Peacock
Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension
Thorax, February 1, 1999; 54(2): 161 - 168.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. T. DE SANCTIS and J. M. DRAZEN
Genetics of Native Airway Responsiveness in Mice
Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): S82 - S88.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. J. MEADE
The Mechanism by Which Epinastine Stops an Adenosine Analog from Contracting BDE Rat Airways
Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 522 - 530.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics.